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ORIGINAL ARTICLE BACTERIOLOGYBlood culture series beneﬁt may be limited to selected clinical conditions:
time to reassessR. Khatib1, G. Simeunovic1, M. Sharma1, M. G. Fakih1, L. B. Johnson1, L. Briski2 and W. Lebar2
1) Department of Medicine and 2) Department of Pathology, St. John Hospital and Medical Center, Grosse Pointe Woods, MI, USAAbstractBlood cultures are often submitted as series (two to three sets per 24 hours) to maximize sample recovery. We assessed the actual beneﬁt of
additional sets. Blood cultures submitted from adults (18 years old) over 1 year (1 February 2012 to 31 January 2013) were examined. The
medical records of patients with positive cultures were reviewed. Cultures with commensal organisms were considered contamination in the
absence of a source and clinical ﬁndings. The impact of additional sets on antibiotic therapy was estimated. We evaluated 15 394 blood
cultures. They were submitted as two to ﬁve sets per 24 hours in 12 236 (79.5%) instances. Pathogens were detected in 1227 sets,
representing 741 bacteremias, of which 618 (83.4%) were detected in the ﬁrst set and 123 (16.6%) in the additional sets. Pathogens
missed in the ﬁrst set were recovered from patients receiving antibiotics (n = 72; 58.5%) and after undergoing a procedure (n = 54;
43.9%). The additional sets’ results could have inﬂuenced antibiotic therapy in 76/6235 (1.2%) instances, including 40 (0.6%) antibiotic
switches and 36 (0.6%) possible extensions of therapy. The potential impact of the detection of missed pathogens on antibiotic therapy
was not apparent in patients who had an endovascular infection (26/27, 96.3%) and those who lacked an obvious source of pathogens
(10/10, 100%). These ﬁndings suggest that one blood culture is probably adequate in patients with an obvious source of pathogens. Blood
culture series are beneﬁcial in patients without an obvious source of pathogens and in those with endovascular infections. It is time to
reassess the beneﬁt of blood culture series, perhaps limiting them to selected conditions.
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E-mail: riad.khatib@stjohn.orgIntroductionDetection of bacteremia or fungemia by blood culture is
essential for proper management of patients with infection.
Current guidelines advocate two to three sets of blood samples
obtained simultaneously from different venipunctures or seri-
ally within 0 to 24 hours for optimal detection of bacteremia
and interpretation of blood culture results [1–5]. The potential
beneﬁts of multiple sets include better detection of bacteremia,Microbiol Infect 2015; 21: 332–336
nical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2014.11.019the ability to distinguish contaminants and the recognition of
persistent bacteremia [4]. Actual beneﬁt has been attributed to
a simple increase in the blood volume assessed rather than to
number of venipunctures [6,7]. These guidelines are based on
several studies that illustrate better detection of bacteremia
with more cultures and with a larger blood volume tested
[2,8–11].
Most of these studies focus on the detection of bacteremia
without assessing the overall beneﬁt of additional sets, whether
they alter the patient management and if they are more appli-
cable to selected clinical settings. As a result of increasing
workloads in the microbiology laboratory, cost containment
efforts and the drive for early initiation of antibiotics, we
assessed the beneﬁt of assessing more than one culture per 24
hours.ious Diseases. Published by Elsevier Ltd. All rights reserved
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Our hospital is an 804-bed teaching hospital in Detroit, Mich-
igan. Our microbiology laboratory receives blood cultures from
inpatients, the emergency department, afﬁliated outpatient
settings and other afﬁliated chronic and acute care facilities. We
selected cultures submitted from our adult (18 years old)
inpatients in the emergency departments and afﬁliated outpa-
tient settings. We excluded cultures from chronic care facilities
and other hospitals. We performed a retrospective evaluation
of the results of blood cultures processed between 1 February
2012 and 31 January 2013.
Blood culture processing
The blood culture system used in our hospital during the study
period was the BacTAlert with FA FAN Aerobic and Anaerobic
bottles (bioMérieux, Marcy l’Étoile, France) with instructions
for 10 mL blood draw per bottle. The phlebotomists are ex-
pected to mark the level of media in each bottle and the desired
ﬁll volume, which is 10 mL in adults, using the premarked 5 mL
increments on the bottle label, before blood collection. Addi-
tionally, about 20% of blood culture bottles are randomly
selected periodically and examined to assure compliance with
proper blood volume ﬁll, with feedback provided to the
phlebotomists.
Assessment of blood cultures
We reviewed the medical records of all patients with positive
cultures. We excluded line draws and patients with inadequate
medical record documentation for assessment. We abstracted
the clinical ﬁndings, the condition at the time of culture, the
source of bacteremia with the source culture results and the
clinician’s approach to the blood culture result. The reviewers
were not blinded to the blood culture results.
Deﬁnitions
A blood culture set was deﬁned as aerobic and anaerobic blood
culture bottles obtained from one venipuncture site. A single
set was deﬁned as one set per 24 hours. Culture series rep-
resented two or more sets per 24 hours. The ﬁrst and addi-
tional sets referred to the ﬁrst and subsequently drawn sets
within 24 hours. In simultaneously drawn sets, the set entered
ﬁrst in the record was considered the ﬁrst. Commensal or-
ganisms signiﬁed organisms recognized as potential contami-
nants such as coagulase-negative staphylococci, viridans group
streptococci, Bacillus spp., Corynebacterium spp., Propionibacte-
rium spp., Aerococcus spp., and Micrococcus spp. Isolation of one
of these organisms was considered true bacteremia in theClinical Microbiology and Infection © 2014 European Society of Clinical Microbiologypresence of a source and clinical signs, contamination in the
absence of a source and clinical signs and of uncertain status in
the presence of a potential source or clinical signs but not both
[10–12]. Cases with uncertain status were counted as bacter-
emias. An episode of bacteremia was deﬁned as the recovery of
the same pathogen from single or multiple sets within the same
day and the recovery of a different pathogen by the additional
sets within the same day.
The impact of the additional set result on antibiotic treat-
ment was estimated on the basis of whether the usual empirical
therapy for the disease process was adequate to cover the
yielded pathogens, if treatment duration needed to be extended
on the basis of documenting persistent bacteremia and if
treatment could have been discontinued.
Statistical methods
The chi-square test was used to assess the signiﬁcance of dif-
ferences in categorical variables, and the signiﬁcance of trends
was assessed by the extended Mantel-Haenszel chi-square test
for linear trend. SPSS software release 20 was used for statis-
tical analysis (IBM, Armonk, NY, USA). A p value of <0.05 was
considered to indicate statistical signiﬁcance.
The study was approved by the St. John Hospital and Medical
Center institutional review board.ResultsStudy population
A total of 18 507 blood cultures were reviewed, of which 3113
were excluded, including 2311 from children, 788 from subjects
from chronic care facilities, four line draws and ten with inad-
equate medical records for assessment. The 15 394 included
cultures were obtained from 5251 patients, encompassing 6854
(44.5%) from the general wards, 6006 (39.0%) from the
emergency department, 1999 (13.0%) from intensive care units,
459 (3.0%) from outpatients and 76 (0.5%) from labor and
delivery.
The cultures were submitted as a single set per 24 hours in
3158 (20.5%) and series of two to ﬁve sets per 24 hours in
12 236 (79.5%) instances, corresponding to 6001 series with
6235 additional sets. The interval between blood cultures sets
was 30 minutes in 4759 (76.3%) of the cases, including 162
(2.6%) simultaneous submissions.
Blood culture results
A total of 2072 organisms were recovered from 1887 (12.3%)
blood culture sets including 1601 pathogens, 404 contaminants
and 67 organisms of uncertain status that were considered
pathogens. The organisms recovered are shown in Table 1.and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 332–336
TABLE 2. Potential impact of bacteremia missed by the ﬁrst
set on antibiotic treatment, stratiﬁed according to clinical
setting
Clinical setting (n)
Impact on antibiotic therapy, n (%)
No change Change Extension
Additional set >1 hour (31) 13 (41.9) 13 (41.9) 5 (16.1)
After a procedure (56)a 15 (26.8) 16 (28.6) 25 (44.6)
Known bacteremic (23) 1 (4.3) 4 (17.4) 18 (78.3)
Polymicrobial (19) 9 (47.4) 8 (42.1) 2 (10.5)
Antibiotics (72) 22 (30.6) 24 (33.3) 26 (36.1)
Source
Vascular (26) 1 (3.8) 8 (30.8) 17 (65.4)
Respiratory (17) 7 (41.2) 3 (17.6) 7 (41.2)
Urine (27) 16 (59.3) 11 (40.7) 0
Other tissue (43) 23 (53.5) 10 (23.2) 10 (23.2)
Unknown (10) 0 8 (80.0) 2 (20.0)
Overall impact (123) 47 (38.2) 40 (32.5) 36 (29.3)
aExchange of blocked indwelling catheters, endotracheal suctioning, incision and
drainage of an abscess and debridement of necrotic tissues.
TABLE 1. Organisms recovered from 1887/15 394 blood







(n [ 1668) (n [ 404)
Staphylococcus aureus (531) 530 (31.5) 1 (0.2)
Enterococcus spp. (164) 143 (8.6) 21 (5.0)
Coagulase-negative staphylococci 398 128 (7.3) 270 (68.1)
Streptococcus pneumoniae (36) 36 (2.2) 0
Streptococcus milleri (21) 21 (1.3) 0
Viridans group streptococci (41) 23 (1.3) 18 (4.5)
β hemolytic streptococci (49) 49 (2.9) 0
Bacillus spp. (37) 11 (0.6) 26 (6.0)
Corynebacterium spp. (44) 7 (0.7) 37 (8.5)
Other Gram-positive organisms (37) 15 (1.2) 22 (5.2)
Escherichia coli (244) 244 (14.6) 0
Other Enterobacteriaceae (250) 250 (15.1) 0
Pseudomonas aeruginosa (56) 56 (3.4) 0
Other Gram-negative bacilli (46) 46 (2.6) 0
Anaerobes (79) 71 (4.3) 8 (2.5)
Yeast (38) 38 (2.4) 0
Mycobacterium mucogen (1) 0 1
334 Clinical Microbiology and Infection, Volume 21 Number 4, April 2015 CMIDetection of pathogens was similar in single set and culture
series (337, 10.7% vs. 1227, 10.0%; p 0.3).
Value of additional blood culture sets
The majority of additional sets (n = 5522; 88.6%) were negative
(Fig. 1). Pathogens were detected in 1227 sets, corresponding
to 741 episodes of bacteremias among 239 patients. These
episodes were detected by the ﬁrst set in 618 (83.4%) instances
and the additional sets in 123 (16.6%) instances. The charac-
teristics of bacteremia missed by the ﬁrst set are shown in
Table 2. Most patients were receiving antibiotic therapy, and
the additional sets were obtained after a procedure such as
exchange of obstructed indwelling urinary catheter, deep res-
piratory suctioning in an intubated patient, incision and drainage
of an abscess or debridement of necrotic tissues. They included
follow-up cultures from patients with known bacteremia andFIG. 1. Results of additional cultures in blood culture series.
Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectinstances of polymicrobial bacteremia with an extra pathogen
identiﬁed in the additional sets. Many of these patients had a
focus of infection with deﬁned microbiology, such as pneu-
monia, urinary tract infection and soft tissue/bone infection,
that would have warranted appropriate antibiotic treatment.
The additional culture set result could have inﬂuenced antibi-
otic therapy in 76/6235 (1.2%) instances, including switching the
antibiotic (n = 40; 0.7%) and extending the therapy (n = 36;
0.6%).
The pathogens missed by the ﬁrst set were detected by the
second set in 119 (96.8%) instances, the third set in three
(2.4%) instances and the fourth set in one (0.8%) instance.
Stratifying culture results according to the interval between
serial cultures revealed that the missed pathogens were least
likely to be recovered in additional sets obtained 0 to 30 mi-
nutes (72/4759, 1.5%) compared to 31 to 60 minutes (14/506,
2.8%) and >61 minutes (31/970, 3.2%) after the ﬁrst set (p
0.0008; extended Mantel-Haenszel chi square for linear trend).DiscussionCurrent guidelines for blood cultures advocate two to three
sets obtained simultaneously or within 24 hours to maximize
recovery of bacteremia and to help in interpreting the isolation
of common contaminants [1,4,5]. For detection of bacteremia,
comparing single to multiple blood cultures is likely to reveal
that the more cultures and/or the larger blood volume, the
better the detection of bloodstream invasion [2,4,5,8–10]. The
major drawback of these studies is the testing of the same
cultures that are being used to deﬁne bacteremia [6] and
focusing on the diagnosis of bacteremia without addressing the
actual impact of blood culture series on antibiotic therapy and
patient outcome. In fact, the usefulness of blood culture inious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 332–336
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pneumonia, has been questioned [12–20]. Blood culture results
in these settings may help optimize antibiotic therapy, but the
beneﬁt of more than one culture has not been substantiated.
Another potential value of multiple blood culture sets is
distinguishing between persistent and transient bacteremia. This
distinction may be valuable in suggesting an intravascular focus
[10] as well as in modifying the treatment duration in Staphy-
lococcus aureus bacteremia [21] and potentially other bacter-
emias, but its relevance in most clinical conditions is largely
unknown.
Our ﬁndings indicate that detection of bacteremia was
improved by testing a second set of samples. However, the
percentage of additional sets with missed pathogens was much
higher in sets obtained after 30 minutes from the ﬁrst culture.
They may have been obtained because of a change in patient
condition, but determining the actual reason for late submission
is difﬁcult to determine retrospectively. Additionally, our ﬁnd-
ings show that the impact of the improved detection by the
additional sets was most apparent in patients with suspected
endovascular foci and those without an obvious source of
infection.
With respect to recognizing contamination, several tools
exist [10,22–26]. They are based on the type of organism, the
clinical features and the proportion of positive cultures. How-
ever, the value of these guidelines in patients at high risk for
infection with common contaminants, such as those with de-
vices or osteomyelitis, and patients receiving antimicrobial
therapy has not been clearly substantiated. Additionally,
detecting different strains in multiple sets may represent
bacteremia in one culture and a contaminant in the other.
Finally, isolating the same contaminant in two blood culture sets
may not always represent bacteremia [26].
Limitations of our study include the retrospective review and
the uncertainty of potential differences in blood draw volume in
the ﬁrst and additional cultures. We also did not examine blood
culture media effects. A signiﬁcant difference in bacterial re-
covery was noted on the basis of the type of media or bottles
[27,28]. Finally, our calculation of the impact of culture results
on patient management and antibiotic therapy was imprecise. It
was estimated on the basis of the presumed empiric antibiotic
therapy and the missed pathogen susceptibility and if detecting
bacteremia could have lead to extension of the duration of
antibiotic therapy such as the ﬁnding of Staphylococcus aureus
bacteremia [21]. Despite these limitations, our ﬁndings suggest
that one blood culture is likely adequate in many conditions.
Additional studies are needed to verify this observation and to
determine whether culture series beneﬁt is more apparent in
selected clinical settings, such as endovascular infections and
the lack of an obvious source of infection.Clinical Microbiology and Infection © 2014 European Society of Clinical MicrobiologyTransparency declarationThe authors declare that they have no conﬂicts of interest.AcknowledgementsThe study was supported by St. John Hospital and the Medical
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